Solve Therapeutics vs Grafana Labs

Side-by-side comparison of AI visibility scores, market position, and capabilities

Grafana Labs leads in AI visibility (45 vs 28)
Solve Therapeutics logo

Solve Therapeutics

EmergingBioTech

Antibody-Drug Conjugates (Solid Tumors)

Raised $120M oversubscribed (Nov 2025) with Merck & Co. as new equity investor. $321M total. CloakLink ADC technology reduces hydrophobicity and toxicity. Two Phase 1b solid tumor trials active.

AI VisibilityBeta
Overall Score
D28
Category Rank
#1 of 1
AI Consensus
60%
Trend
up
Per Platform
ChatGPT
37
Perplexity
33
Gemini
34

About

Solve Therapeutics develops antibody-drug conjugates (ADCs) using its proprietary CloakLink technology — which reduces the hydrophobicity and systemic toxicity that are the two primary causes of ADC clinical failure. The company raised $120 million in an oversubscribed financing round in November 2025, with Merck & Co. making a direct equity investment (rather than a typical licensing deal), bringing total funding to $321 million. Two ADC programs (SLV-154 and SLV-324) are in active Phase 1b trials in solid tumor patients.

Full profile
Grafana Labs logo

Grafana Labs

ChallengerIT Operations & Observability

Metrics Visualization

Open-source observability leader with $6B valuation; Grafana dashboards plus Loki/Tempo/Mimir stack serving millions of installations as Datadog alternative with community-driven adoption.

AI VisibilityBeta
Overall Score
C45
Category Rank
#1 of 1
AI Consensus
62%
Trend
down
Per Platform
ChatGPT
46
Perplexity
41
Gemini
36

About

Grafana Labs is the company behind Grafana — the world's most widely used open-source observability and data visualization platform — providing the Grafana Cloud managed service, Grafana Enterprise, and a suite of open-source tools including Loki (log aggregation), Tempo (distributed tracing), and Mimir (long-term Prometheus metrics storage). Founded in 2019 by Raj Dutt, Torkel Ödegaard, and Tom Wilkie (the creators of the original Grafana open-source project) in New York, Grafana Labs has raised over $600 million at a $6 billion valuation.\n\nGrafana's open-source project — downloadable and self-hostable for free — has driven extraordinary community adoption: millions of Grafana installations globally power engineering, IoT, and business dashboards at organizations from startups to large enterprises. Grafana's plugin ecosystem connects to 200+ data sources (Prometheus, InfluxDB, Elasticsearch, AWS CloudWatch, databases), making it the universal observability visualization layer. Grafana Cloud packages the open-source tools into a fully managed SaaS offering with unlimited metrics, logs, traces, and dashboards.\n\nIn 2025, Grafana Labs competes in the observability platform market against Datadog, New Relic, Dynatrace, and the ELK/OpenSearch stack for enterprise monitoring and observability. Grafana's open-source-first model creates a moat through developer community and ecosystem — engineers who build personal dashboards on Grafana become advocates for Grafana Cloud at their employers. The company's OpenTelemetry alignment and multi-source data philosophy ("query any data, anywhere") differentiates it from Datadog's monolithic agent model. The 2025 strategy focuses on growing Grafana Cloud enterprise adoption, advancing AI-powered Sift (automatic anomaly investigation), and expanding the Grafana IRM (incident response management) product.

Full profile

AI Visibility Head-to-Head

28
Overall Score
45
#1
Category Rank
#1
60
AI Consensus
62
up
Trend
down
37
ChatGPT
46
33
Perplexity
41
34
Gemini
36
24
Claude
53
22
Grok
46

Capabilities & Ecosystem

Capabilities

Only Solve Therapeutics
Antibody-Drug Conjugates (Solid Tumors)
Only Grafana Labs
Metrics Visualization
Grafana Labs is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.